Peter Buttrick
Concepts (556)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myocardium | 53 | 2018 | 982 | 3.650 |
Why?
| Heart Ventricles | 18 | 2023 | 741 | 2.320 |
Why?
| Heart Failure | 21 | 2023 | 2114 | 2.120 |
Why?
| Cardiomegaly | 20 | 2013 | 168 | 1.980 |
Why?
| Myocardial Contraction | 22 | 2011 | 339 | 1.950 |
Why?
| Protein Kinase C | 19 | 2014 | 314 | 1.890 |
Why?
| Ventricular Dysfunction, Right | 7 | 2023 | 232 | 1.810 |
Why?
| Myocytes, Cardiac | 13 | 2022 | 483 | 1.640 |
Why?
| Troponin I | 10 | 2013 | 83 | 1.400 |
Why?
| Isoenzymes | 17 | 2002 | 303 | 1.130 |
Why?
| Heart | 21 | 2022 | 649 | 1.030 |
Why?
| Ventricular Function, Right | 6 | 2023 | 262 | 0.990 |
Why?
| Myosins | 18 | 2018 | 130 | 0.910 |
Why?
| Muscle Proteins | 4 | 2022 | 218 | 0.900 |
Why?
| Actin Cytoskeleton | 6 | 2011 | 103 | 0.830 |
Why?
| Phosphorylation | 19 | 2016 | 1733 | 0.810 |
Why?
| Heart-Assist Devices | 3 | 2012 | 487 | 0.810 |
Why?
| Cardiomyopathy, Dilated | 6 | 2018 | 349 | 0.750 |
Why?
| Ventricular Remodeling | 8 | 2023 | 230 | 0.730 |
Why?
| Protein Kinase C-epsilon | 9 | 2007 | 31 | 0.730 |
Why?
| Hypertension, Pulmonary | 8 | 2023 | 1900 | 0.720 |
Why?
| Myosin Light Chains | 4 | 2013 | 35 | 0.700 |
Why?
| Scientific Misconduct | 1 | 2019 | 12 | 0.690 |
Why?
| Carrier Proteins | 5 | 2022 | 740 | 0.680 |
Why?
| Sarcomeres | 7 | 2021 | 92 | 0.660 |
Why?
| Physical Conditioning, Animal | 8 | 2006 | 206 | 0.650 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 5 | 2011 | 139 | 0.640 |
Why?
| Rats | 48 | 2013 | 5426 | 0.630 |
Why?
| Neprilysin | 1 | 2018 | 47 | 0.630 |
Why?
| Stroke Volume | 8 | 2023 | 553 | 0.620 |
Why?
| Animals | 86 | 2023 | 34133 | 0.590 |
Why?
| Editorial Policies | 1 | 2017 | 53 | 0.560 |
Why?
| Cardiac Myosins | 2 | 2013 | 33 | 0.540 |
Why?
| Calcium | 11 | 2011 | 1244 | 0.540 |
Why?
| Myocardial Ischemia | 4 | 2019 | 267 | 0.530 |
Why?
| Myocardial Infarction | 8 | 2013 | 1134 | 0.520 |
Why?
| Adrenergic beta-Agonists | 5 | 2002 | 134 | 0.520 |
Why?
| Gene Expression Regulation | 8 | 2019 | 2491 | 0.510 |
Why?
| Histone Deacetylases | 2 | 2013 | 202 | 0.490 |
Why?
| Clinical Trials as Topic | 1 | 2019 | 985 | 0.490 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 6 | 2021 | 252 | 0.480 |
Why?
| Serine | 3 | 2013 | 142 | 0.480 |
Why?
| Periodicals as Topic | 1 | 2017 | 239 | 0.470 |
Why?
| Ventricular Function, Left | 4 | 2011 | 493 | 0.470 |
Why?
| Valproic Acid | 1 | 2013 | 46 | 0.450 |
Why?
| Rats, Wistar | 15 | 2006 | 405 | 0.450 |
Why?
| Hydroxamic Acids | 1 | 2013 | 80 | 0.450 |
Why?
| Mitogen-Activated Protein Kinases | 3 | 2002 | 306 | 0.420 |
Why?
| Aortic Valve Stenosis | 2 | 2013 | 315 | 0.420 |
Why?
| Ventricular Dysfunction, Left | 5 | 2023 | 401 | 0.410 |
Why?
| Isoproterenol | 6 | 2004 | 127 | 0.410 |
Why?
| RNA, Messenger | 15 | 2017 | 2720 | 0.380 |
Why?
| Recovery of Function | 2 | 2011 | 610 | 0.370 |
Why?
| Induced Pluripotent Stem Cells | 3 | 2021 | 188 | 0.370 |
Why?
| Dobutamine | 5 | 2005 | 36 | 0.350 |
Why?
| Mice | 27 | 2022 | 15888 | 0.350 |
Why?
| Apoptosis | 4 | 2002 | 2532 | 0.340 |
Why?
| Gene Expression | 12 | 2017 | 1506 | 0.340 |
Why?
| Receptors, Adrenergic, beta | 3 | 2011 | 146 | 0.330 |
Why?
| Angiotensin Receptor Antagonists | 3 | 1997 | 93 | 0.320 |
Why?
| Phosphoserine | 2 | 2007 | 34 | 0.320 |
Why?
| Cattle | 6 | 2023 | 994 | 0.310 |
Why?
| Protein Processing, Post-Translational | 5 | 2016 | 421 | 0.310 |
Why?
| Humans | 51 | 2023 | 122796 | 0.310 |
Why?
| Tissue and Organ Procurement | 1 | 2010 | 243 | 0.310 |
Why?
| Catecholamines | 5 | 2022 | 103 | 0.310 |
Why?
| Muscle Strength | 1 | 2010 | 290 | 0.310 |
Why?
| Adrenergic beta-Antagonists | 2 | 2017 | 334 | 0.310 |
Why?
| Hypertrophy, Right Ventricular | 3 | 2023 | 148 | 0.300 |
Why?
| Phenotype | 2 | 2013 | 3070 | 0.300 |
Why?
| Pharmacogenetics | 1 | 2008 | 151 | 0.300 |
Why?
| Disease Models, Animal | 10 | 2023 | 3799 | 0.300 |
Why?
| Glycolysis | 2 | 2012 | 227 | 0.290 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2008 | 228 | 0.290 |
Why?
| Mitochondria, Heart | 1 | 2007 | 85 | 0.290 |
Why?
| Biophysics | 1 | 2007 | 74 | 0.290 |
Why?
| NAD | 1 | 2007 | 68 | 0.290 |
Why?
| Cytosol | 1 | 2007 | 229 | 0.280 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 2006 | 74 | 0.280 |
Why?
| Hypoxia-Inducible Factor 1 | 2 | 2006 | 68 | 0.280 |
Why?
| Mice, Transgenic | 13 | 2018 | 2079 | 0.280 |
Why?
| Transforming Growth Factor beta | 2 | 2020 | 468 | 0.270 |
Why?
| Fibroblasts | 4 | 2020 | 846 | 0.260 |
Why?
| Hypertension, Renovascular | 3 | 1994 | 16 | 0.260 |
Why?
| Models, Animal | 1 | 2007 | 373 | 0.260 |
Why?
| Hypertension | 5 | 2007 | 1245 | 0.260 |
Why?
| MAP Kinase Signaling System | 1 | 2006 | 304 | 0.250 |
Why?
| Polymorphism, Genetic | 1 | 2008 | 666 | 0.250 |
Why?
| Myosin Heavy Chains | 3 | 2004 | 193 | 0.250 |
Why?
| Calcineurin | 2 | 2002 | 96 | 0.250 |
Why?
| Renin-Angiotensin System | 2 | 1996 | 83 | 0.250 |
Why?
| Models, Biological | 2 | 2021 | 1756 | 0.240 |
Why?
| Male | 37 | 2020 | 59639 | 0.240 |
Why?
| Endothelium, Vascular | 3 | 2019 | 923 | 0.240 |
Why?
| Gene Transfer Techniques | 3 | 2000 | 154 | 0.240 |
Why?
| Angiotensin II | 2 | 2001 | 108 | 0.230 |
Why?
| GATA4 Transcription Factor | 2 | 2020 | 19 | 0.230 |
Why?
| Chronic Disease | 2 | 2020 | 1645 | 0.220 |
Why?
| Cardiovascular Diseases | 3 | 2007 | 1859 | 0.220 |
Why?
| Female | 47 | 2020 | 63629 | 0.220 |
Why?
| Thromboxane A2 | 2 | 2002 | 13 | 0.220 |
Why?
| Cardiac Output, Low | 1 | 2002 | 78 | 0.210 |
Why?
| Rats, Inbred Strains | 14 | 1992 | 392 | 0.210 |
Why?
| Genetic Therapy | 3 | 2000 | 265 | 0.200 |
Why?
| Fatty Acids, Unsaturated | 1 | 2002 | 87 | 0.200 |
Why?
| Proto-Oncogene Proteins | 2 | 2002 | 646 | 0.200 |
Why?
| Heart Diseases | 2 | 2019 | 358 | 0.200 |
Why?
| Calcium Signaling | 3 | 2011 | 232 | 0.200 |
Why?
| Cyclosporine | 1 | 2001 | 175 | 0.200 |
Why?
| Diabetes Mellitus, Experimental | 2 | 2004 | 213 | 0.190 |
Why?
| Alternative Splicing | 1 | 2022 | 197 | 0.190 |
Why?
| Gene Expression Regulation, Developmental | 3 | 2021 | 852 | 0.190 |
Why?
| Organ Size | 12 | 2001 | 474 | 0.190 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2002 | 165 | 0.190 |
Why?
| Biomedical Research | 1 | 2007 | 630 | 0.190 |
Why?
| Brachial Artery | 1 | 2002 | 183 | 0.190 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 1003 | 0.190 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 59 | 0.190 |
Why?
| Adaptation, Physiological | 4 | 2012 | 510 | 0.190 |
Why?
| Tetrazoles | 2 | 1997 | 32 | 0.180 |
Why?
| Hemodynamics | 8 | 2011 | 1036 | 0.180 |
Why?
| RNA, Long Noncoding | 1 | 2022 | 163 | 0.180 |
Why?
| Blood Pressure | 11 | 2012 | 1713 | 0.180 |
Why?
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 122 | 0.180 |
Why?
| Signal Transduction | 9 | 2021 | 4902 | 0.180 |
Why?
| Animals, Newborn | 5 | 2011 | 825 | 0.180 |
Why?
| Phototherapy | 1 | 2019 | 27 | 0.180 |
Why?
| Cardiotonic Agents | 3 | 2005 | 133 | 0.180 |
Why?
| Cell Dedifferentiation | 1 | 2019 | 30 | 0.180 |
Why?
| Molecular Sequence Data | 8 | 2012 | 2933 | 0.180 |
Why?
| Heart Rate | 8 | 2007 | 756 | 0.170 |
Why?
| Lysosomal-Associated Membrane Protein 2 | 1 | 2018 | 24 | 0.170 |
Why?
| Autophagosomes | 1 | 2018 | 21 | 0.170 |
Why?
| Glycogen Storage Disease Type IIb | 1 | 2018 | 20 | 0.170 |
Why?
| Cells, Cultured | 13 | 2021 | 4162 | 0.170 |
Why?
| Cocaine | 2 | 1991 | 157 | 0.170 |
Why?
| Circadian Clocks | 1 | 2019 | 48 | 0.170 |
Why?
| Membrane Fusion | 1 | 2018 | 40 | 0.170 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2018 | 240 | 0.170 |
Why?
| Imidazoles | 2 | 1997 | 234 | 0.170 |
Why?
| Body Weight | 10 | 2001 | 958 | 0.170 |
Why?
| Cell Culture Techniques | 1 | 2021 | 354 | 0.160 |
Why?
| Amphiregulin | 1 | 2018 | 21 | 0.160 |
Why?
| In Vitro Techniques | 8 | 2011 | 1130 | 0.160 |
Why?
| Filamins | 1 | 2018 | 17 | 0.160 |
Why?
| Lysosomes | 1 | 2018 | 136 | 0.160 |
Why?
| Systole | 3 | 2005 | 178 | 0.160 |
Why?
| Adenosine Triphosphatases | 5 | 2005 | 160 | 0.160 |
Why?
| Receptors, Histamine H2 | 1 | 2017 | 10 | 0.160 |
Why?
| Actomyosin | 1 | 1997 | 10 | 0.150 |
Why?
| Aging | 5 | 2008 | 1694 | 0.150 |
Why?
| Myocardial Reperfusion Injury | 1 | 2018 | 107 | 0.150 |
Why?
| Activities of Daily Living | 1 | 2020 | 361 | 0.150 |
Why?
| Physical Exertion | 3 | 1988 | 231 | 0.150 |
Why?
| Period Circadian Proteins | 2 | 2019 | 22 | 0.150 |
Why?
| Mice, Inbred C57BL | 8 | 2020 | 5020 | 0.150 |
Why?
| Coronary Circulation | 4 | 2004 | 121 | 0.150 |
Why?
| Protein Kinase C beta | 6 | 2008 | 26 | 0.150 |
Why?
| Patient Participation | 1 | 2020 | 371 | 0.150 |
Why?
| Angiotensin I | 1 | 1996 | 4 | 0.150 |
Why?
| Myofibrils | 2 | 2021 | 50 | 0.150 |
Why?
| Hypoxia | 4 | 2023 | 1003 | 0.150 |
Why?
| Sex Characteristics | 3 | 2006 | 690 | 0.140 |
Why?
| Enzyme Inhibitors | 5 | 2002 | 836 | 0.140 |
Why?
| Amino Acid Substitution | 2 | 2007 | 278 | 0.140 |
Why?
| Middle Aged | 11 | 2020 | 28563 | 0.140 |
Why?
| Cellular Reprogramming Techniques | 1 | 2015 | 15 | 0.140 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 196 | 0.130 |
Why?
| Coronary Artery Disease | 1 | 2002 | 695 | 0.130 |
Why?
| rho-Associated Kinases | 1 | 2015 | 85 | 0.130 |
Why?
| Ultrasonography | 2 | 2012 | 740 | 0.130 |
Why?
| Heart Transplantation | 4 | 2011 | 674 | 0.130 |
Why?
| Time Factors | 8 | 2009 | 6682 | 0.130 |
Why?
| Cellular Reprogramming | 1 | 2015 | 88 | 0.130 |
Why?
| Coronary Vessels | 2 | 1987 | 237 | 0.120 |
Why?
| Atrial Natriuretic Factor | 2 | 2007 | 59 | 0.120 |
Why?
| Tetracycline | 1 | 1994 | 15 | 0.120 |
Why?
| Transcription, Genetic | 3 | 2019 | 1355 | 0.120 |
Why?
| Blotting, Western | 2 | 2015 | 1225 | 0.120 |
Why?
| Interleukin-18 | 1 | 2016 | 229 | 0.120 |
Why?
| Echocardiography | 2 | 2009 | 591 | 0.120 |
Why?
| Amino Acid Sequence | 4 | 2012 | 2123 | 0.120 |
Why?
| Renin | 1 | 1993 | 36 | 0.120 |
Why?
| Cardiac Output | 3 | 2012 | 154 | 0.120 |
Why?
| Cell Differentiation | 1 | 2021 | 1805 | 0.120 |
Why?
| Transfection | 3 | 1993 | 909 | 0.110 |
Why?
| Protein Phosphatase 1 | 1 | 2013 | 34 | 0.110 |
Why?
| Sodium, Dietary | 1 | 1993 | 44 | 0.110 |
Why?
| Protein Phosphatase 2 | 1 | 2013 | 42 | 0.110 |
Why?
| Immunohistochemistry | 4 | 2018 | 1727 | 0.110 |
Why?
| Substance-Related Disorders | 2 | 1991 | 958 | 0.110 |
Why?
| Antihypertensive Agents | 1 | 1996 | 465 | 0.110 |
Why?
| Protein Disulfide-Isomerases | 1 | 2012 | 10 | 0.110 |
Why?
| Antibodies | 2 | 2013 | 400 | 0.110 |
Why?
| Contractile Proteins | 5 | 1996 | 17 | 0.110 |
Why?
| Cell Line | 6 | 2021 | 2785 | 0.110 |
Why?
| Muscle Fibers, Skeletal | 2 | 2005 | 197 | 0.110 |
Why?
| Receptor, Adenosine A2B | 1 | 2012 | 32 | 0.110 |
Why?
| Ventricular Function | 2 | 1991 | 61 | 0.100 |
Why?
| In Situ Nick-End Labeling | 2 | 2002 | 124 | 0.100 |
Why?
| Aorta | 2 | 2007 | 368 | 0.100 |
Why?
| Practice Patterns, Physicians' | 1 | 2020 | 1267 | 0.100 |
Why?
| Disease Progression | 3 | 2009 | 2546 | 0.100 |
Why?
| Excitation Contraction Coupling | 1 | 2011 | 18 | 0.100 |
Why?
| Ventricular Pressure | 1 | 2011 | 42 | 0.100 |
Why?
| Natriuretic Peptides | 1 | 2011 | 7 | 0.100 |
Why?
| Enzyme Activation | 3 | 2002 | 864 | 0.100 |
Why?
| Hyperbaric Oxygenation | 1 | 2011 | 42 | 0.100 |
Why?
| Desmin | 1 | 2010 | 32 | 0.100 |
Why?
| Ventricular Fibrillation | 1 | 1991 | 56 | 0.100 |
Why?
| Neurotransmitter Agents | 1 | 2011 | 76 | 0.100 |
Why?
| Epoprostenol | 3 | 1986 | 141 | 0.090 |
Why?
| Peptide Fragments | 2 | 2007 | 715 | 0.090 |
Why?
| Chest Pain | 1 | 1990 | 94 | 0.090 |
Why?
| Spectrophotometry, Ultraviolet | 1 | 2010 | 76 | 0.090 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 108 | 0.090 |
Why?
| Histone Deacetylase Inhibitors | 1 | 2012 | 202 | 0.090 |
Why?
| Promoter Regions, Genetic | 6 | 1994 | 1188 | 0.090 |
Why?
| Extracellular Matrix Proteins | 1 | 2011 | 133 | 0.090 |
Why?
| Cyclic AMP | 3 | 2008 | 260 | 0.090 |
Why?
| Cardiovascular Physiological Phenomena | 2 | 2006 | 40 | 0.090 |
Why?
| Rats, Sprague-Dawley | 5 | 2012 | 2501 | 0.090 |
Why?
| Proto-Oncogene Proteins c-akt | 2 | 2002 | 433 | 0.090 |
Why?
| Energy Metabolism | 3 | 2007 | 783 | 0.090 |
Why?
| Blotting, Northern | 2 | 2001 | 199 | 0.090 |
Why?
| Prosthesis Design | 1 | 2011 | 293 | 0.090 |
Why?
| Adult | 11 | 2020 | 32385 | 0.090 |
Why?
| Mice, Knockout | 3 | 2022 | 2737 | 0.090 |
Why?
| Biopsy | 1 | 2013 | 1090 | 0.090 |
Why?
| Sex Factors | 2 | 2013 | 1860 | 0.090 |
Why?
| Platelet Aggregation | 3 | 1986 | 98 | 0.080 |
Why?
| Muscle, Smooth, Vascular | 1 | 2012 | 454 | 0.080 |
Why?
| Mitochondria | 1 | 2014 | 809 | 0.080 |
Why?
| MicroRNAs | 2 | 2015 | 661 | 0.080 |
Why?
| Toxicogenetics | 1 | 2008 | 1 | 0.080 |
Why?
| Digoxin | 1 | 2008 | 29 | 0.080 |
Why?
| Cell Hypoxia | 2 | 2019 | 229 | 0.080 |
Why?
| Biomarkers, Pharmacological | 1 | 2008 | 29 | 0.080 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2010 | 493 | 0.080 |
Why?
| Mutation | 2 | 2018 | 3493 | 0.080 |
Why?
| Magnetic Resonance Spectroscopy | 3 | 2007 | 513 | 0.080 |
Why?
| Tandem Mass Spectrometry | 1 | 2010 | 423 | 0.080 |
Why?
| Embryo, Mammalian | 2 | 2020 | 222 | 0.080 |
Why?
| RNA | 2 | 2006 | 854 | 0.080 |
Why?
| Arrhythmias, Cardiac | 2 | 2022 | 310 | 0.080 |
Why?
| Gene Expression Regulation, Enzymologic | 4 | 2002 | 294 | 0.080 |
Why?
| Consensus Sequence | 1 | 2007 | 70 | 0.080 |
Why?
| Protein Conformation | 1 | 2010 | 851 | 0.070 |
Why?
| Ligation | 1 | 2007 | 83 | 0.070 |
Why?
| Biophysical Phenomena | 1 | 2007 | 65 | 0.070 |
Why?
| Oxidation-Reduction | 2 | 2007 | 931 | 0.070 |
Why?
| Clinical Medicine | 1 | 2007 | 21 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2001 | 1981 | 0.070 |
Why?
| Heat Shock Transcription Factors | 1 | 2006 | 18 | 0.070 |
Why?
| Carnitine O-Palmitoyltransferase | 1 | 2007 | 48 | 0.070 |
Why?
| Aged | 8 | 2020 | 20495 | 0.070 |
Why?
| Pregnancy, Animal | 1 | 1987 | 58 | 0.070 |
Why?
| Base Sequence | 5 | 1994 | 2186 | 0.070 |
Why?
| Thyroid Hormones | 3 | 1993 | 56 | 0.070 |
Why?
| National Institutes of Health (U.S.) | 1 | 2007 | 122 | 0.070 |
Why?
| Chloramphenicol O-Acetyltransferase | 4 | 1994 | 36 | 0.070 |
Why?
| Nitroimidazoles | 1 | 2006 | 7 | 0.070 |
Why?
| Butyrates | 1 | 2007 | 55 | 0.070 |
Why?
| Receptors, Corticotropin-Releasing Hormone | 1 | 2006 | 33 | 0.070 |
Why?
| Retrospective Studies | 3 | 2012 | 13433 | 0.070 |
Why?
| Sequence Analysis, RNA | 2 | 2021 | 420 | 0.070 |
Why?
| Heat-Shock Proteins | 1 | 2006 | 129 | 0.070 |
Why?
| DNA-Binding Proteins | 2 | 2006 | 1384 | 0.070 |
Why?
| Heart Atria | 1 | 1986 | 121 | 0.070 |
Why?
| Corticotropin-Releasing Hormone | 1 | 2006 | 86 | 0.070 |
Why?
| Longitudinal Studies | 1 | 2012 | 2599 | 0.070 |
Why?
| Swimming | 5 | 1990 | 47 | 0.070 |
Why?
| Case-Control Studies | 1 | 2013 | 3296 | 0.070 |
Why?
| Age Factors | 3 | 2008 | 3114 | 0.070 |
Why?
| Transcription Factors | 2 | 2006 | 1616 | 0.060 |
Why?
| Mitochondrial Proteins | 1 | 2007 | 231 | 0.060 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 336 | 0.060 |
Why?
| Cloning, Molecular | 3 | 1997 | 551 | 0.060 |
Why?
| Phenylephrine | 2 | 2021 | 85 | 0.060 |
Why?
| Enzyme Induction | 1 | 2004 | 94 | 0.060 |
Why?
| Animals, Genetically Modified | 1 | 2005 | 227 | 0.060 |
Why?
| Osteopontin | 1 | 2004 | 39 | 0.060 |
Why?
| Cell Proliferation | 1 | 2012 | 2328 | 0.060 |
Why?
| Ventricular Myosins | 1 | 2004 | 33 | 0.060 |
Why?
| Sialoglycoproteins | 1 | 2004 | 162 | 0.060 |
Why?
| Kinetics | 3 | 2011 | 1658 | 0.060 |
Why?
| Drug Resistance | 1 | 2004 | 169 | 0.060 |
Why?
| Anticoagulants | 1 | 2008 | 589 | 0.060 |
Why?
| Mutagenesis | 1 | 2004 | 185 | 0.060 |
Why?
| Rats, Inbred F344 | 4 | 1997 | 245 | 0.060 |
Why?
| Recombinant Fusion Proteins | 2 | 2004 | 661 | 0.060 |
Why?
| Exercise Therapy | 1 | 1987 | 375 | 0.060 |
Why?
| Calcium-Transporting ATPases | 3 | 1993 | 36 | 0.060 |
Why?
| Severity of Illness Index | 1 | 2011 | 2784 | 0.060 |
Why?
| Cytokines | 1 | 2011 | 1928 | 0.060 |
Why?
| Up-Regulation | 2 | 2007 | 891 | 0.060 |
Why?
| Receptors, Adrenergic, alpha | 1 | 2002 | 33 | 0.050 |
Why?
| Massachusetts | 1 | 2022 | 140 | 0.050 |
Why?
| RNA Splicing Factors | 1 | 2022 | 51 | 0.050 |
Why?
| Chromones | 1 | 2002 | 41 | 0.050 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 102 | 0.050 |
Why?
| Pulsatile Flow | 1 | 2002 | 54 | 0.050 |
Why?
| United States | 3 | 2022 | 13272 | 0.050 |
Why?
| GTP-Binding Proteins | 1 | 2002 | 151 | 0.050 |
Why?
| Androstadienes | 1 | 2002 | 95 | 0.050 |
Why?
| Muscles | 3 | 1994 | 336 | 0.050 |
Why?
| Hypertrophy | 1 | 2001 | 125 | 0.050 |
Why?
| Flavonoids | 1 | 2001 | 73 | 0.050 |
Why?
| Lac Operon | 1 | 2001 | 47 | 0.050 |
Why?
| beta-Galactosidase | 1 | 2001 | 67 | 0.050 |
Why?
| In Situ Hybridization, Fluorescence | 1 | 2022 | 319 | 0.050 |
Why?
| Morpholines | 1 | 2002 | 111 | 0.050 |
Why?
| Protein Isoforms | 1 | 2022 | 347 | 0.050 |
Why?
| Calcium Channels, L-Type | 1 | 2002 | 113 | 0.050 |
Why?
| Substrate Specificity | 1 | 2002 | 375 | 0.050 |
Why?
| Immunoblotting | 1 | 2001 | 318 | 0.050 |
Why?
| Sarcoplasmic Reticulum | 2 | 1993 | 43 | 0.050 |
Why?
| American Heart Association | 1 | 2022 | 313 | 0.050 |
Why?
| Culture Media | 1 | 2021 | 165 | 0.050 |
Why?
| Collagen | 2 | 2016 | 436 | 0.050 |
Why?
| Health Services Misuse | 1 | 2020 | 36 | 0.050 |
Why?
| Outpatients | 1 | 2023 | 336 | 0.050 |
Why?
| Cardiac Pacing, Artificial | 3 | 1998 | 90 | 0.050 |
Why?
| Protein Transport | 1 | 2001 | 418 | 0.050 |
Why?
| Carotid Arteries | 1 | 2001 | 189 | 0.040 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2018 | 2127 | 0.040 |
Why?
| Reactive Oxygen Species | 1 | 2002 | 592 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2022 | 432 | 0.040 |
Why?
| MAP Kinase Kinase Kinase 1 | 1 | 1999 | 14 | 0.040 |
Why?
| Biomechanical Phenomena | 2 | 1996 | 705 | 0.040 |
Why?
| Qa-SNARE Proteins | 1 | 2018 | 14 | 0.040 |
Why?
| Immediate-Early Proteins | 1 | 1999 | 56 | 0.040 |
Why?
| R-SNARE Proteins | 1 | 2018 | 19 | 0.040 |
Why?
| Organ Culture Techniques | 2 | 2007 | 152 | 0.040 |
Why?
| Action Potentials | 2 | 2015 | 433 | 0.040 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2018 | 49 | 0.040 |
Why?
| Autophagy-Related Proteins | 1 | 2018 | 48 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2018 | 107 | 0.040 |
Why?
| Blood Platelets | 3 | 1986 | 369 | 0.040 |
Why?
| Protein-Tyrosine Kinases | 1 | 2002 | 442 | 0.040 |
Why?
| Tachycardia | 1 | 1998 | 57 | 0.040 |
Why?
| Hypertension, Renal | 2 | 1989 | 28 | 0.040 |
Why?
| Cell Survival | 1 | 2001 | 1075 | 0.040 |
Why?
| Streptozocin | 1 | 1997 | 23 | 0.040 |
Why?
| Protein Biosynthesis | 2 | 1997 | 408 | 0.040 |
Why?
| Prazosin | 1 | 1997 | 24 | 0.040 |
Why?
| Hypertrophy, Left Ventricular | 1 | 1998 | 112 | 0.040 |
Why?
| Fatty Acids | 1 | 2021 | 410 | 0.040 |
Why?
| Microarray Analysis | 1 | 2018 | 124 | 0.040 |
Why?
| Adrenergic alpha-Agonists | 1 | 1997 | 31 | 0.040 |
Why?
| Research Design | 2 | 2022 | 1002 | 0.040 |
Why?
| Death, Sudden | 1 | 1997 | 34 | 0.040 |
Why?
| Pharmacogenomic Variants | 1 | 2017 | 35 | 0.040 |
Why?
| Electrocardiography | 2 | 1991 | 620 | 0.040 |
Why?
| Adenosine Triphosphate | 3 | 2011 | 456 | 0.040 |
Why?
| Endothelial Cells | 1 | 2023 | 749 | 0.040 |
Why?
| Epinephrine | 3 | 1988 | 166 | 0.040 |
Why?
| Threonine | 1 | 1997 | 48 | 0.040 |
Why?
| Regional Blood Flow | 2 | 2012 | 427 | 0.040 |
Why?
| Biomarkers | 2 | 2013 | 3662 | 0.040 |
Why?
| Diastole | 2 | 1988 | 147 | 0.040 |
Why?
| Integrases | 1 | 2018 | 123 | 0.040 |
Why?
| Europe | 1 | 2018 | 369 | 0.040 |
Why?
| Proteomics | 1 | 2023 | 890 | 0.040 |
Why?
| Alanine | 1 | 1997 | 103 | 0.040 |
Why?
| DNA Mutational Analysis | 1 | 2018 | 390 | 0.040 |
Why?
| Treatment Outcome | 1 | 2011 | 9692 | 0.040 |
Why?
| Cell Adhesion | 1 | 2018 | 454 | 0.040 |
Why?
| DNA Methylation | 1 | 2020 | 511 | 0.040 |
Why?
| Point Mutation | 1 | 1997 | 231 | 0.040 |
Why?
| Mutagenesis, Site-Directed | 1 | 1997 | 368 | 0.040 |
Why?
| Dogs | 1 | 1997 | 382 | 0.030 |
Why?
| Peptides | 1 | 2001 | 893 | 0.030 |
Why?
| Regulatory Sequences, Nucleic Acid | 2 | 1993 | 84 | 0.030 |
Why?
| Chemokine CXCL12 | 1 | 2016 | 81 | 0.030 |
Why?
| Physician-Patient Relations | 1 | 2020 | 509 | 0.030 |
Why?
| Histones | 1 | 2020 | 562 | 0.030 |
Why?
| MEF2 Transcription Factors | 1 | 2015 | 60 | 0.030 |
Why?
| Creatine Kinase | 2 | 1997 | 76 | 0.030 |
Why?
| RNA, Small Interfering | 1 | 2018 | 581 | 0.030 |
Why?
| Chromatin Immunoprecipitation | 1 | 2015 | 139 | 0.030 |
Why?
| Phosphofructokinase-1 | 1 | 2014 | 7 | 0.030 |
Why?
| Biological Transport | 1 | 1996 | 392 | 0.030 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2016 | 167 | 0.030 |
Why?
| T-Box Domain Proteins | 1 | 2015 | 96 | 0.030 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 1260 | 0.030 |
Why?
| Oligonucleotide Probes | 1 | 1994 | 54 | 0.030 |
Why?
| Glucose Transporter Type 4 | 1 | 2014 | 39 | 0.030 |
Why?
| Luciferases | 2 | 1992 | 150 | 0.030 |
Why?
| Electron Transport Complex I | 1 | 2014 | 37 | 0.030 |
Why?
| Antibody Specificity | 2 | 2013 | 190 | 0.030 |
Why?
| Succinate Dehydrogenase | 1 | 1994 | 44 | 0.030 |
Why?
| Troponin | 1 | 1994 | 51 | 0.030 |
Why?
| Oxygen Consumption | 3 | 1997 | 613 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 346 | 0.030 |
Why?
| Cytochalasin B | 1 | 1974 | 17 | 0.030 |
Why?
| Binding Sites, Antibody | 1 | 1974 | 40 | 0.030 |
Why?
| Connexin 43 | 1 | 1994 | 26 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2017 | 1184 | 0.030 |
Why?
| Gene Expression Profiling | 1 | 2021 | 1625 | 0.030 |
Why?
| Adenoviridae | 1 | 1994 | 195 | 0.030 |
Why?
| DNA Copy Number Variations | 1 | 2014 | 167 | 0.030 |
Why?
| Thyroxine | 1 | 1994 | 64 | 0.030 |
Why?
| Norepinephrine | 3 | 1992 | 214 | 0.030 |
Why?
| Recombinant Proteins | 1 | 1997 | 1318 | 0.030 |
Why?
| Fibrosis | 1 | 2015 | 497 | 0.030 |
Why?
| Cytomegalovirus | 1 | 1993 | 144 | 0.030 |
Why?
| Erythrocytes | 2 | 1977 | 636 | 0.030 |
Why?
| Quality Improvement | 1 | 2020 | 1004 | 0.030 |
Why?
| Immunodominant Epitopes | 1 | 2012 | 27 | 0.030 |
Why?
| Avian Sarcoma Viruses | 1 | 1992 | 4 | 0.030 |
Why?
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 38 | 0.030 |
Why?
| Transcriptional Activation | 1 | 1994 | 360 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2012 | 64 | 0.030 |
Why?
| Genes, Viral | 1 | 1992 | 94 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2014 | 537 | 0.030 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2012 | 140 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 104 | 0.030 |
Why?
| Perfusion | 2 | 1997 | 160 | 0.030 |
Why?
| Cardioplegic Solutions | 1 | 2011 | 6 | 0.030 |
Why?
| Phosphorus Radioisotopes | 1 | 2011 | 29 | 0.030 |
Why?
| Rabbits | 3 | 1993 | 808 | 0.030 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2005 | 2221 | 0.030 |
Why?
| src-Family Kinases | 1 | 2012 | 109 | 0.030 |
Why?
| Buffers | 1 | 2011 | 56 | 0.030 |
Why?
| Benzamides | 1 | 2012 | 175 | 0.020 |
Why?
| Calcium Channel Blockers | 1 | 1991 | 121 | 0.020 |
Why?
| Antigen Presentation | 1 | 2012 | 198 | 0.020 |
Why?
| Swine | 1 | 2013 | 777 | 0.020 |
Why?
| New York City | 1 | 1990 | 78 | 0.020 |
Why?
| Histocompatibility Antigens Class I | 1 | 2012 | 176 | 0.020 |
Why?
| Muscle, Skeletal | 2 | 1997 | 1556 | 0.020 |
Why?
| Education, Medical, Continuing | 1 | 1991 | 140 | 0.020 |
Why?
| Women's Health | 1 | 1992 | 277 | 0.020 |
Why?
| Endoplasmic Reticulum | 1 | 2012 | 250 | 0.020 |
Why?
| Growth Hormone | 1 | 1990 | 109 | 0.020 |
Why?
| T-Lymphocytes | 2 | 1994 | 1814 | 0.020 |
Why?
| Gonadal Steroid Hormones | 1 | 1990 | 123 | 0.020 |
Why?
| Pyrimidines | 1 | 2012 | 388 | 0.020 |
Why?
| Genes | 1 | 1989 | 231 | 0.020 |
Why?
| Phosphocreatine | 2 | 1999 | 38 | 0.020 |
Why?
| Genetic Predisposition to Disease | 1 | 2017 | 2359 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2013 | 1947 | 0.020 |
Why?
| Pyridines | 1 | 2012 | 440 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 1988 | 137 | 0.020 |
Why?
| Cell Size | 1 | 2008 | 86 | 0.020 |
Why?
| Citric Acid Cycle | 1 | 2007 | 45 | 0.020 |
Why?
| Palmitic Acid | 1 | 2007 | 39 | 0.020 |
Why?
| Risk Factors | 2 | 1991 | 9381 | 0.020 |
Why?
| Heart Function Tests | 1 | 2007 | 68 | 0.020 |
Why?
| DNA | 2 | 1991 | 1401 | 0.020 |
Why?
| Mitral Valve Stenosis | 1 | 1986 | 21 | 0.020 |
Why?
| Peptide Hormones | 1 | 2006 | 8 | 0.020 |
Why?
| Mitral Valve Insufficiency | 1 | 1986 | 65 | 0.020 |
Why?
| Prospective Studies | 1 | 2018 | 6704 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6845 | 0.020 |
Why?
| Stress, Mechanical | 1 | 2007 | 440 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2013 | 2977 | 0.020 |
Why?
| Phentolamine | 1 | 1985 | 17 | 0.020 |
Why?
| Antibodies, Monoclonal | 1 | 2012 | 1306 | 0.020 |
Why?
| Adenosine Diphosphate | 1 | 1985 | 89 | 0.020 |
Why?
| Actins | 1 | 1987 | 409 | 0.020 |
Why?
| Cardiovascular System | 1 | 2006 | 132 | 0.020 |
Why?
| Vascular Resistance | 1 | 1986 | 374 | 0.020 |
Why?
| Rats, Inbred BN | 1 | 2004 | 51 | 0.020 |
Why?
| Rats, Inbred Lew | 1 | 2004 | 87 | 0.020 |
Why?
| Homeostasis | 1 | 2008 | 596 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 2 | 1999 | 547 | 0.010 |
Why?
| Algorithms | 1 | 2011 | 1593 | 0.010 |
Why?
| Motor Activity | 1 | 1988 | 679 | 0.010 |
Why?
| Prognosis | 1 | 1991 | 3563 | 0.010 |
Why?
| Phenanthridines | 1 | 2002 | 6 | 0.010 |
Why?
| Benzophenanthridines | 1 | 2002 | 10 | 0.010 |
Why?
| Alkaloids | 1 | 2002 | 23 | 0.010 |
Why?
| Papillary Muscles | 1 | 2002 | 16 | 0.010 |
Why?
| Mesylates | 1 | 2002 | 8 | 0.010 |
Why?
| Aspirin | 1 | 1985 | 344 | 0.010 |
Why?
| Detergents | 1 | 2002 | 46 | 0.010 |
Why?
| Second Messenger Systems | 1 | 2002 | 32 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2002 | 162 | 0.010 |
Why?
| Glucose | 1 | 2007 | 968 | 0.010 |
Why?
| Glucocorticoids | 1 | 2006 | 554 | 0.010 |
Why?
| Membrane Potentials | 1 | 2002 | 273 | 0.010 |
Why?
| Exercise | 1 | 1992 | 1743 | 0.010 |
Why?
| Fetus | 2 | 1997 | 699 | 0.010 |
Why?
| Pyrroles | 1 | 2002 | 199 | 0.010 |
Why?
| Tamoxifen | 1 | 1981 | 198 | 0.010 |
Why?
| Phosphates | 1 | 2001 | 170 | 0.010 |
Why?
| Calcium-Binding Proteins | 1 | 2001 | 222 | 0.010 |
Why?
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 46 | 0.010 |
Why?
| Early Growth Response Protein 1 | 1 | 1999 | 31 | 0.010 |
Why?
| Deoxyuracil Nucleotides | 1 | 1998 | 2 | 0.010 |
Why?
| DNA Nucleotidylexotransferase | 1 | 1998 | 11 | 0.010 |
Why?
| Binding Sites | 1 | 2002 | 1247 | 0.010 |
Why?
| Constriction | 1 | 1998 | 46 | 0.010 |
Why?
| Nucleic Acid Hybridization | 2 | 1989 | 193 | 0.010 |
Why?
| DNA Ligases | 1 | 1998 | 16 | 0.010 |
Why?
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 178 | 0.010 |
Why?
| Estrogens | 2 | 1992 | 325 | 0.010 |
Why?
| Aorta, Abdominal | 1 | 1998 | 43 | 0.010 |
Why?
| Carbohydrates | 1 | 1977 | 61 | 0.010 |
Why?
| Erythrocyte Membrane | 1 | 1977 | 52 | 0.010 |
Why?
| Protein Kinase C-alpha | 1 | 1997 | 43 | 0.010 |
Why?
| Protein Kinase C-delta | 1 | 1997 | 69 | 0.010 |
Why?
| beta-Thromboglobulin | 2 | 1986 | 3 | 0.010 |
Why?
| Thromboxane B2 | 2 | 1986 | 28 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2007 | 3264 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 11094 | 0.010 |
Why?
| Running | 2 | 1988 | 233 | 0.010 |
Why?
| RNA, Transfer, Leu | 1 | 1994 | 7 | 0.010 |
Why?
| Pregnancy | 1 | 1987 | 5854 | 0.010 |
Why?
| Nuclear Proteins | 1 | 1999 | 618 | 0.010 |
Why?
| Immune Adherence Reaction | 1 | 1974 | 2 | 0.010 |
Why?
| Atrophy | 1 | 1994 | 167 | 0.010 |
Why?
| Intercellular Junctions | 1 | 1994 | 34 | 0.010 |
Why?
| Neuraminidase | 1 | 1974 | 24 | 0.010 |
Why?
| Vibrio cholerae | 1 | 1974 | 8 | 0.010 |
Why?
| Leucine | 1 | 1994 | 117 | 0.010 |
Why?
| Melanoma | 1 | 1981 | 709 | 0.010 |
Why?
| Polymerase Chain Reaction | 1 | 1997 | 1021 | 0.010 |
Why?
| Genes, Reporter | 1 | 1994 | 274 | 0.010 |
Why?
| Tissue Distribution | 1 | 1994 | 339 | 0.010 |
Why?
| Recombination, Genetic | 1 | 1994 | 175 | 0.010 |
Why?
| Chick Embryo | 1 | 1993 | 131 | 0.010 |
Why?
| Immune System | 1 | 1994 | 184 | 0.010 |
Why?
| Skin Neoplasms | 1 | 1981 | 841 | 0.010 |
Why?
| Genetic Vectors | 1 | 1993 | 310 | 0.010 |
Why?
| Adolescent | 1 | 2011 | 18948 | 0.010 |
Why?
| DNA, Bacterial | 1 | 1993 | 324 | 0.010 |
Why?
| Denervation | 1 | 1992 | 21 | 0.010 |
Why?
| Oxygen | 1 | 1997 | 887 | 0.010 |
Why?
| Sheep | 1 | 1974 | 769 | 0.010 |
Why?
| Triiodothyronine | 1 | 1991 | 45 | 0.010 |
Why?
| Temperature | 1 | 1974 | 631 | 0.010 |
Why?
| Hypothyroidism | 1 | 1991 | 69 | 0.010 |
Why?
| Models, Cardiovascular | 1 | 1992 | 183 | 0.010 |
Why?
| Heart Valve Diseases | 1 | 1992 | 137 | 0.010 |
Why?
| Injections | 1 | 1991 | 171 | 0.010 |
Why?
| Orchiectomy | 1 | 1990 | 58 | 0.010 |
Why?
| Plasmids | 1 | 1991 | 358 | 0.010 |
Why?
| Ovariectomy | 1 | 1990 | 125 | 0.010 |
Why?
| Hematocrit | 1 | 1990 | 94 | 0.010 |
Why?
| DNA Probes | 1 | 1989 | 62 | 0.010 |
Why?
| Histocytochemistry | 1 | 1989 | 84 | 0.010 |
Why?
| Chickens | 1 | 1989 | 188 | 0.010 |
Why?
| Lactates | 1 | 1988 | 87 | 0.010 |
Why?
| Testosterone | 1 | 1990 | 353 | 0.000 |
Why?
| Child | 1 | 1986 | 19561 | 0.000 |
Why?
| Lactic Acid | 1 | 1988 | 283 | 0.000 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1986 | 21 | 0.000 |
Why?
| Kidney | 1 | 1993 | 1355 | 0.000 |
Why?
| Lymphatic Metastasis | 1 | 1981 | 310 | 0.000 |
Why?
| Hemagglutination | 1 | 1977 | 7 | 0.000 |
Why?
| Mitogens | 1 | 1977 | 61 | 0.000 |
Why?
| Antibody Formation | 1 | 1977 | 285 | 0.000 |
Why?
| Lymphocytes | 1 | 1977 | 360 | 0.000 |
Why?
|
|
Buttrick's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|